Comparative study of efficacy, safety and patient compliance of Dapagliflozin(anti diabetic drug) and Metformin(anti diabetic drug) Vs Vildagliptin(anti diabetic drug) and Metformin combination therapy in newly diagnosed Type 2 diabetes patients
Phase 4
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2020/12/030147
- Lead Sponsor
- Kumar Gautam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Newly diagnosed T2DM patients with or without metformin therapy 2)HbA1C >=7.5 3)Age 18-75 yrs
Exclusion Criteria
1)Type 1DM, Patient taking metformin 1000mg/day with poor glycemic control
2)eGFR <45 ml/min/1.73m2
3)CHF
4)Pregnancy
5)Lactation
6)Patients with Child bearing potential
7)Active Malignancy 8)Chronic inflammatory disorders
9)Chronic alcoholism
10)History of pancreatitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method